Moreover, TCGA database revealed that EGR1 in lung adenocarcinoma patients (LUAD) was significantly lower than in noncancerous tissue, and the downregulation level of EGR1 was associated with poor prognosis and short survival inversely (Figures 8C, D). This evidence concerns the gene EGR1 and lung adenocarcinoma.